Abstract. Erythropoietin (Epo) is a key regulator of erythroid cell proliferation, differentiation and apoptosis. In the form of the recombinant protein, it is widely used to treat various types of anemias, including that associated with cancer and with the myelosuppressive effects of chemotherapy, particularly platinum-based regimens. Our previous studies confirmed the presence of Epo receptors (EpoRs) in ovarian adenocarcinoma cell lines and demonstrated that long-term Epo treatment of A2780 cells resulted in the development of a phenotype exhibiting both enhanced Epo signaling and increased paclitaxel resistance. In the present study, we carried out a series of experiments to analyze the pro-angiogenic potential of Epo-treated A2780 and SKOV-3 cells. Our studies revealed that conditioned media of Epo-treated A2780 cells had a stimulative effect on human umbilical vein endothelial cells (HUVECs). This effect was only seen when A2780 cells were incubated under hypoxic conditions. Furthermore, Epo increased the secretion of interleukin (IL)-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, GM-CSF and interferon-γ by A2780 cells that grew in hypoxic conditions. In this regard, conditioned media of hypoxic and Epo-treated A2780 cells induced a significant phosphorylation of STAT-5 in HUVECs. Our results may have important implications for ovarian cancer patients receiving Epo.
Introduction
Erythropoietin (Epo) is a glycoprotein that regulates the growth, maturation, and survival of erythroid progenitor cells. Epo has received attention for its role(s) outside of hematopoiesis (1) . Several groups have demonstrated the presence of the Epo receptor (EpoR) expressed by ovarian cancer cells (2) (3) (4) (5) with differing results regarding its localization and functionality. Our previous studies revealed a weak surface EpoR signal in A2780 cells with most of EpoR found in the cytoplasm, more abundantly as an intracellular membraneassociated protein than a soluble one. Silencing EpoR expression resulted in reduced A2780 proliferation as well as a reduction in Epo-induced phosphorylation of Erk1/2 (6) . The presence and the functionality of EpoR have been confirmed in several other cancer cells. Unlike hematopoietic cells, where Epo/EpoR signaling is associated with increased cell proliferation and/or survival, in tumor cells the Epo/EpoR axis does not always lead to increased proliferation but may increase the resistance of cancer cells to different therapies. Szenajch et al (7) provide a critical review of this.
In 1990, Anagnostou et al (8) found that recombinant human Epo (rhEpo) enhances the proliferation and migration of human umbilical vein endothelial cells (HUVECs) and bovine adrenal capillary endothelial cells (9, 10) and demonstrated the presence of EpoR mRNA in HUVECs as well as strong positive EpoR protein staining of the vascular endothelium in vivo (11) . The presence of EpoR was also shown by Yamaji et al (12) , who suggested that brain capillary endothelial cells express not only an authentic form of EpoR but also a soluble one and that Epo acts directly on brain capillary endothelial cells as a competence factor. In vivo angiogenic potential of Epo was originally demonstrated by Yasuda et al (13) who found that injection of Epo into the ovariectomized mouse uterine cavity promoted blood vessel formation of the endometrium. Similarly, Ribatti et al (14) demonstrated that Epo induced a potent in vivo angiogenic response of the chick embryo chorioallantoic membrane. Furthermore, the role of Epo in the physiological angiogenesis was described during wound healing and in the developing of mouse embryo (15, 16) .
The study of Yasuda et al (17) revealed that normal human cervix, endometrium as well as ovary malignant tumors of female reproductive organs produce Epo and EpoR, and that the tumor cells themselves and capillary endothelial cells are sites responsive to the Epo signal. Based on the mitogenic action of Epo as well as the finding that injection of soluble EpoR or Epo-monoclonal antibody into the tumor was followed by apoptosis of tumor cells, Yasuda et al (18) proposed the presence of a paracrine or autocrine Epo/EpoR loop and its contribution to tumorigenesis in female reproductive organs. Subsequently, Epo-induced angiogenesis was demonstrated on chemically induced murine hepatic tumors (19) , glioma tumor cells in chick embryo chorioallantoic membrane (20) and melanoma cells in Matrigel plug assay (21) . Epo also accelerated the growth of EpoR negative Lewis lung carcinoma cells by promoting tumor angiogenesis in vivo (22) . Notably, Epo/ EpoR levels correlated well with angiogenesis and progression of patients with hepatocellular carcinoma, neuroblastoma, squamous cell carcinoma of the tongue, melanoma and gastric adenocarcinoma (23) (24) (25) (26) (27) . Although studies have not confirmed a direct stimulatory effect of rhEpo on tumor cells, there is ample evidence of this effect on endothelial cell proliferation and/or angiogenesis of tumors. We have now carried out a series of experiments to explore mechanisms of such an endothelial cell stimulation induced by conditioned media of diverse ovarian adenocarcinoma cells A2780 and SKOV-3. Both cell lines were incubated either in normoxic or hypoxic conditions and their conditioned media were investigated in order to test the proliferation of HUVECs. The potential pro-angiogenic effect of rhEpo, which remains in the conditioned media of rhEpo-treated A2780 and SKOV-3 cells, was also studied.
Materials and methods
Cell culture conditions. Human ovarian adenocarcinoma cell lines A2780 and SKOV-3 were obtained from the American Tissue Culture Collection. Both cell lines were grown in RPMI-1640 with L-glutamine (Life Technologies, Carlsbad, CA, USA). Media was supplemented with 10% FCS (Life Technologies) and antibiotic/antimycotic solution (100 U/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B; Life Technologies). The cells were maintained under standard tissue culture conditions of 37˚C, 95% air/5% CO 2 .
HUVECs were isolated, cultured, and characterized as previously described (28, 29) . Cells were cultured on gelatin-coated dishes in M199 media supplemented with 10% heat-inactivated human serum (PAA, Piscataway, NJ, USA), 10% heat-inactivated new born calf serum (Cambrex, East Rutherford, NJ, USA), 150 µg/ml crude endothelial cell growth factor (ECGF), 5 U/ml heparin, 100 IU/ml penicillin, and 100 µg/ml streptomycin (Sigma-Aldrich, St. Louis, MO, USA) at 37˚C under a 5% CO 2 /95% air atmosphere. Twenty-four hours prior to the experiments, the endothelial cell cultures were refreshed with a media without crude ECGF and heparin.
Cell culture treatments. A2780 and SKOV-3 cells were seeded at a density of 1x10 6 cells/Petri dish in RPMI-1640 media with 10% FCS for 24 h. Subsequently, cells were washed with PBS and serum-free media with or without 50 U/ml of rhEpo (Eprex ® ; Janssen-Cilag, Beerse, Belgium) was added. Half of the experimental Petri dishes were then moved to a hypoxic chamber with 1% O 2 and the other half were kept under standard tissue culture conditions, both for 24 h. Conditioned media were then immediately added to HUVECs for 48-h cell proliferation assay.
HUVEC proliferation assay. Endothelial cells were seeded at a density of 8x10 3 cells/cm 2 in 24-well plates. Twenty-four hours after seeding, the conditioned media obtained from A2780 and SKOV-3 cells were added to endothelial cells in triplicate wells. Vascular endothelial growth factor (VEGF)-treated cells (R&D Systems, Minneapolis, MN, USA) (25 ng/ml) were used as a positive control. After 48 h of culturing, the proliferation activity was determined using Coulter Counter (Model ZF; Coulter Electronics Ltd., Luton, Bedfordshire, UK) and the total viability was analyzed by staining cells with 0.15% eosine via light microscopy. Cell pellets, after being washed extensively with PBS, were dispersed in antifade mounting fluid, placed on glass slides SuperFrost Plus (Menzel Gläser, Braunschweig, Germany) and used for light microscopy using a Leica DMI6000 microscope at x400 magnification.
RNA isolation, reverse transcription and quantitative RT-PCR.
Total RNA was isolated using TRIzol (Gibco, Invitrogen, Grand Island, NY, USA) and purified using RNeasy Mini kit (Qiagen, Hamburg, Germany). The RNA concentration was quantified at 260 nm and 1 µg of RNA was transcribed using SuperScript II (Invitrogen, Carlsbad, CA, USA) reverse transcriptase and oligo(dT) primers (Invitrogen). Quantitative RT-PCRs were performed in duplicates by iCycler iQ™ Real-Time PCR Detection System (Bio-Rad Laboratories, Inc., Hercules, CA, USA) in 30 µl reaction volume containing 1X iQ™ SYBR Green Supermix (0.2 mM dNTP, 3 mM MgCl 2 ), 0.5 µM forward and reverse primer and 2 µl of cDNA. The reaction conditions were: 95˚C 3 min, 40 cycles (94˚C 30 sec, 55˚C 50 sec, 72˚C 50 sec), 72˚C 7 min followed by melting curve analysis to confirm amplification of the desired single and specific product. The relative expression levels of hypoxiainducible factor-1α (HIF-1α), Epo, VEGF and β-actin genes (primers designed by SABiosciences) were evaluated using the standard curve method. Standard curves for HIF-1α, Epo, VEGF and β-actin were obtained by amplification of seriallydiluted mixtures of cDNA samples (four-fold dilutions), with four to five dilution points, each in duplicate. The calculated resulting relative expression of HIF-1α, Epo, VEGF genes were normalized to relative β-actin expression. The results are presented as mean ± standard deviation of three independent experiments.
Western blot analysis. Western blot analyses were performed according to the standard protocol. HUVECs were incubated with conditioned media of A2780 cells for 30 min. Then, the cells were washed twice with ice-cold PBS and scraped into RIPA buffer (PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS; all Sigma) containing freshly added protease and phosphatase inhibitor cocktail (Roche Diagnostics GmbH, Penzberg, Germany). Scraped lysates were transferred into a microcentrifuge tube and passed through a 21-gauge needle to shear the DNA. Following incubation of the lysates on ice for 45 min, the samples were centrifuged at 10,000 x g for 10 min at 4˚C and the supernatant was transferred into a new microcentrifuge tube. The protein samples were separated on 10% SDS-PAGE gels, electroblotted onto Immobilon-P transfer membrane (Millipore Co., Billerica, MA, USA) and incubated using the following primary antibodies:
anti-STAT5 (AF2168, 1:200; R&D Systems), anti-phospho-STAT5 (Y694/Y699) (AF4190, 1:100; R&D Systems), anti p44/42 MAP kinase (#9102, 1:1,000; Cell Signaling Technology, Danvers, MA, USA), anti-phospho-p44/42 MAP kinase (#9272, 1:1,000; Cell Signaling Technology) and anti-β-actin (clone AC-74, 1:10,000; Sigma). The membranes were then incubated with secondary horseradish peroxidaseconjugated antibodies [goat anti-rabbit immunoglobulin G (IgG) F(AB9) 2, 1:10,000, PI-31461, goat anti-mouse IgG F(AB9) 2, 1:10,000, PI-31436 or rabbit anti-goat IgG F(AB9) 2, 1:10,000, PI-31403; Pierce, Rockford, IL, USA] for 1 h, and the antibody reactivity was visualized with ECL western blotting substrate (PI-32106; Pierce) using Kodak BioMax film (#1788207; Sigma).
ELISA assay. ELISA assay with Epo and VEGF detection was performed according to the manufacturer's instructions (R&D Systems). Briefly, 96-well plates with diluent, standards, positive control and experimental samples were incubated for 2 h at room temperature and then each well was washed three times with washing solution. After the addition of VEGF or Epo conjugate, the plates were incubated for another 2 h at room temperature. Subsequently, substrates were added after repeated washing and plates were incubated protected from light for a further 20 min. The enzymatic reaction was stopped by addition of stop solution and absorbance was measured at λ =450 nm using a FLUOStar Optima universal microplate reader (BMG Labtech, Inc., Offenburg, Germany). The concentrations of Epo and VEGF in conditioned media were calculated based on standard curves.
Multi-analyte ELISA assay. The Mix-N-Match Multi-Analyte ELISArray kit (Qiagen) was identical to the common ELISA assay in protocol and development or incubation time. We used this assay to profile the levels of the following 12 cytokines: IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, GM-CSF, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1).
Statistical analysis. Data were processed using scientific graphing and Origin analysis software (OriginLab Co., Northampton, MA, USA) and statistically analyzed using one-way ANOVA followed by Tukey's multiple comparison tests.
Results
We observed the effect of conditioned media of untreated as well as rhEpo-treated A2780 and SKOV-3 cells mainly due to changes in gene expression of HIF-1α, Epo and VEGF as well as in connection with the change of VEGF 165 secretion in both A2780 and SKOV-3 cell lines. Markedly, we found that the expression of HIF-1α did not increase in A2780 cells after 24 h of incubation in hypoxia and, in the case of SKOV-3 cells, the expression of HIF-1α even significantly decreased (probably by the mechanism of feedback regulation). Both A2780 and SKOV-3 cells showed >95% viability after hypoxia incubation (data not shown). The administration of rhEpo, however, had no effect on the expression of HIF-1α in both cell lines in either normoxic or hypoxic conditions (Fig. 1) .
We analyzed the expression of the Epo gene and measured the amount of secreted endogenous Epo in conditioned media of A2780 and SKOV-3 cells under normoxic as well as hypoxic conditions. The expression of Epo was monitored by real-time PCR and clearly showed the presence of low concentrations of mRNA for Epo in both cell lines. The Epo expression was higher in A2780 compared to SKOV-3 cells (Fig. 2A) . Furthermore, hypoxic conditions did not result in any stimulatory effect on the expression of Epo in A2780 and SKOV-3 cells. In addition, ELISA test results clearly showed low production of a secreted form of Epo protein under normoxia in both A2780 as well as SKOV-3 cells (Fig. 2B) . Although the Epo gene expression remained unchanged in both cell lines under conditions of hypoxia ( Fig. 2A) , the concentration of secreted Epo protein increased from 5.3 to 38.9 mU/ml in conditioned media of hypoxic A2780 cells compared to normoxic ones. On the other hand, the concentration of secreted Epo in the conditioned media of SKOV-3 cells did not change under hypoxic conditions compared with normoxic ones (Fig. 2B) . With regard to the application of rhEpo, we did not find any significant effect of 50 U/ml of rhEpo on the expression of Epo gene in A2780 and SKOV-3 cells (Fig. 2A) .
In contrast to Epo and HIF-1α, the expression of VEGF was upregulated through the hypoxic conditions in both A2780 as well as SKOV-3 cells (Fig. 3A) without additional upregulation using rhEpo. The only change in VEGF expression after administration of rhEpo occurred when A2780 cells were incubated with a higher dose of rhEpo under normoxic conditions. Indeed, 150 U/ml enhanced the expression of VEGF in A2780 under normoxia, which was accompanied paradoxically by a decrease in VEGF 165 secretion. Based on the application of anti-Epo antibody or soluble EpoR and observing even stronger decline of VEGF 165 secretion, we hypothesized that it was a non-specific effect of such a high concentration of rhEpo (data not shown). However, enhanced mRNA level of VEGF under the hypoxia correlated well with higher secretion of VEGF 165 in the SKOV-3 cell line only (Fig. 3B) . On the other hand, rhEpo upregulated VEGF secretion in SKOV-3 cells under normoxic conditions without altering the gene expression for VEGF (Fig. 3) . The pro-angiogenic potential of conditioned media from A2780 and SKOV-3 cells was monitored by HUVEC proliferation. All conditioned media, including those originating from A2780 and SKOV-3 cells incubated with 50 U/ml of rhEpo as well as control with rhVEGF and rhEpo were added to HUVECs for 48 h. The result of stimulation and/or proliferation was evaluated by simple counting of HUVECs using the Coulter Counter. In this regard, conditioned media of A2780 and SKOV-3 cells kept under normoxic conditions had no significant effect on the proliferation of HUVECs compared with rhVEGF control (Fig. 4A) . The opposite was observed when HUVECs were incubated with conditioned media of hypoxic A2780 and SKOV-3 cells. These media significantly increased the proliferation of HUVECs compared with rhVEGF control and compared with conditioned media of A2780 and SKOV-3 cells incubated under normoxic conditions (Fig. 4A) . A marked finding was that conditioned media collected from A2780 cells incubated under hypoxic conditions with 50 U/ml of rhEpo had a more pronounced stimulatory effect on HUVECs than the media of hypoxic A2780 cells without rhEpo. Paradoxically, conditioned media of SKOV-3 cells incubated under hypoxic conditions with the same concentration of rhEpo inhibited the proliferation of HUVECs compared to media of hypoxic SKOV-3 cells without rhEpo (Fig. 4) . In order to establish the actual proportion of Epo to stimulate HUVECs, we used neutralizing anti-Epo monoclonal antibody. The stimulation of HUVECs by conditioned media of hypoxic A2780 cells as well as by hypoxic media of rhEpo-treated A2780 cells was blocked using anti-Epo antibody. Contrary to A2780, we did not observe the same blocking effect of anti-Epo antibody in the case of conditioned media of SKOV-3 cells incubated under hypoxic conditions with or without rhEpo (Fig. 4) . In this regard, inhibition of HUVECs by hypoxic media of SKOV-3 cells with rhEpo was probably not related to Epo but was due to alternative factors. On the other hand, it appears that endogenous Epo secreted by A2780 cells under hypoxic conditions but also rhEpo added into media of hypoxic A2780 cells could play an important role in the stimulation of endothelial cells represented in our experiment by HUVECs. The effect of such a 'hypoxic' Epo stimulation was also confirmed by increased phosphorylation of STAT-5 protein in HUVECs and by blocking of such signal using anti-Epo antibody (Fig. 5) . We also monitored the phosphorylation of Erk1/2 proteins, but there was no marked difference induced by hypoxia or due to rhEpo application; we only observed the difference in Erk1/2 phosphorylation between the conditioned media in general compared with rhVEGF or rhEpo controls (Fig. 5A ).
To better understand A2780 conditioned media and its composition in terms of pro-and anti-angiogenic factors, we tested the alterations in the levels of selected cytokines using multi ELISA assay. Based on the results of HUVEC stimulation by conditioned media, we focused more on the content of selected cytokines in conditioned media of A2780 cells treated with rhEpo under hypoxic conditions. It is of note that in this hypoxic media of A2780 cells with rhEpo we found elevated concentrations of IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, GM-CSF and IFN-γ compared with conditioned media of A2780 hypoxic cells without rhEpo treatment as well as compared with conditioned media of normoxic A2780 cells with or without rhEpo (Fig. 6) . The role of rhEpo-induced secretion of the mentioned cytokines in A2780 cells under hypoxic conditions as well as the role of these cytokines in HUVEC stimulation will be studied in our future studies. 
Discussion
Epo stimulates cells through its interaction with the EpoR on the cell surface. The EpoR has been identified not only in the hematopoietic cells, but also in a number of non-hematopoietic cells and tissues (30) . Despite the fact that several of the tumor cells were confirmed by the presence of the EpoR, the discrepancy in the stimulatory effect of Epo on these cells remains. On the one hand, there are published reports that indicate the proliferative response of cancer cells following rhEpo treatment (31-33) , on the other hand, tumor cells, in spite of evidence of EpoR functionality (4,6), did not exhibit a growth Epo response (4, 5, 34) . Although Paragh et al (5) suggested the Epo-independent, EpoR-mediated pathway in the growth of some types of human cancer, additional experiments aimed at typing EpoR are necessary to clarify this contradiction.
There is increasing experimental evidence on the stimulatory effect of Epo on endothelial cell proliferation and/or angiogenesis of tumors. Epo secreted by glioma tumor cells affected glioma vascular endothelial cells via its receptor and promoted angiogenesis in a paracrine manner (20) ; recently, Epo induced angiogenesis in Matrigel plug assays, and neutralization of Epo secreted by melanoma cells resulted in decreased angiogenesis (21) .
Our results provide evidence of the effect of conditioned media of different ovarian adenocarcinoma A2780 and SKOV-3 cells on the proliferation of HUVECs. We hypothesized a stimulatory effect of conditioned media of A2780 and SKOV-3 cells that grew under hypoxic conditions on HUVECs. Our new finding is the fact that pro-stimulatory effect of hypoxic A2780 media, but not SKOV-3, was partly mediated by Epo protein. This was confirmed by increased secretion of Epo by A2780 cells under hypoxia but mainly via the blocking effect of anti-Epo on HUVEC proliferation. Nevertheless, the key drivers of angiogenesis are VEGF molecules (35) , at least in A2780 cells Epo appears to also be an important stimulus. An interesting fact remains that despite increased A2780 cell secretion of Epo molecules, neither HIF-1α or Epo gene overexpression in these cells was observed. This result was probably due to increased stabilization of Epo protein. On the other hand, SKOV-3 cells with eight times higher mRNA levels for HIF-1α than A2780 cells, respond to hypoxia by increased VEGF expression associated with enhanced secretion of VEGF into the media. Increase of VEGF secretion was observed in SKOV-3 cells also after incubation with rhEPO in normoxic conditions without altering VEGF gene expression. Our previous study showed that SKOV-3 compared to A2780 cells constitutive expression of Akt and basal level of phosphorylated Ser473 (activated by overexpression of HER2), which was even enhanced after 24 h incubation of SKOV-3 cells with rhEpo in normoxic conditions (36) . Taking into account that activation of the PI3K/Akt/mTOR pathway can increase (37) and considering our previous results (36) rhEpo now increased secretion of VEGF in SKOV-3 cells under normoxia probably by activation of the Akt pathway followed by increased stabilization of VEGF mRNA or higher translation of VEGF protein.
The mechanism of tumor growth in the context of Epo is not completely clarified, and it remains unclear whether there is a direct effect of Epo in tumor cells as opposed to exogenous effect on angiogenesis (26) . We previously demonstrated that each of four human ovarian cancer cell lines, A2780, CaOV, SKOV-3 and OVCAR-3, expresses the EpoR but none of the cell lines exhibited a growth response in culture to exogenous Epo in normoxic conditions (38) . Presently, rhEpo (50 U/ml) did not affect the proliferation of hypoxic A2780 and SKOV-3 cells measured by incorporation of BrdU (data not shown). rhEpo did not even affect the expression of selected genes associated with tumor angiogenesis. If there were any changes in the expression of HIF-1α, Epo and VEGF, they were induced by lower oxygen pressure not by exogenous Epo. This finding is in contrast with results of Hale et al (39) where Epo significantly reduced hypoxia-induced VEGF expression in SKOV-3 and MCF-7 cells. However, the authors did not use anti-Epo or soluble EpoR to confirm specificity of Epo effect. Our result with stimulatory effects of conditioned media of hypoxic A2780 cells treated with rhEpo on HUVECs is also in contrast to the findings of Hale et al (39) . This effect was, however, the specific effect of Epo due to its blocking via anti-Epo antibody.
Epo signaling as a mitogen of endothelial cells was conducted via tyrosine phosphorylation of proteins including phosphorylation of transcription factor STAT-5, which is similar to that occurring in erythroid cells (40) . Moreover, experiments performed in cultured vascular cells demonstrated that Epo strongly induced phosphorylation of STAT-5 in HUVECs, but only very weakly in smooth muscle cells (41) . We observed STAT-5 signalization in HUVECs after their 30-min incubation with either conditioned media of hypoxic A2780 cells with or without addition of rhEpo or conditioned media of normoxic A2780 cells with rhEpo. Notably, we found the association between increased phosphorylation of STAT-5 and HUVEC stimulation only in hypoxic media of A2780 cells with or without rhEpo, not in normoxic media with rhEpo. On the other hand, anti-Epo antibody significantly reduced A2780 hypoxic media with or without rhEpo induced STAT-5 phosphorylation as well as proliferation of HUVECs. The stimulative effect of secreted as well as rhEpo on HUVECs could be explained by different levels of pro-and anti-angiogenic cytokines secreted by A2780 cells under the hypoxic conditions compared with normoxic ones.
Cancer cells secrete several angiogenic factors, such as VEGF, bFGF, PDGF, IL-6 and IL-8 (42-45) and cytokines, such as MCP-1, G-CSF, M-CSF, TNFα, IL-1α and IL-1β (46) (47) (48) (49) . These cytokines could bind to their receptors expressed by endothelial and hematopoietic/lymphoid cells and induce production of additional types of cytokines (50) . In this regard, IL-6 produced by human ovarian epithelial cells (43) can stimulate inflammatory cytokine production, tumor angiogenesis and the tumor macrophage infiltrate in ovarian cancer (51) . On the other hand, IL-10 had suppressive effects on angiogenesis, tumor growth, and peritoneal dissemination of VEGF-producing ovarian cancer cells (52) . IL-4 as well as IL-13 inhibited the migration of cultured bovine or human microvascular cells, showing unusual dose-response curves that were sharply stimulatory at a concentration of 0.01 ng/ml but inhibitory over a wide range of higher concentrations (53) . Similarly, IL-12, a cytokine with both immunostimulatory and anti-angiogenic effects, suppressed both tumor-associated angiogenesis and growth of canine hemangiosarcoma in vivo (54) . The treatment of A2780 cells with rhEpo under hypoxic conditions led to increased secretion of IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, GM-CSF and IFN-γ cytokines. The role of individual pro-and anti-angiogenic cytokines in HUVEC stimulation will be examined in future studies. It is critical to determine which cytokines are secreted by HUVECs in response to conditioned media with or without Epo. The final effect of Epo on HUVECs will probably depend on the balance between pro-and anti-angiogenic cytokines in an environment of HUVECs.
Our results revealed that conditioned media of rhEpo-treated A2780 cells under hypoxic conditions induced significant STAT-5 phosphorylation as well as proliferation of HUVECs. Furthermore, rhEpo increased secretion of IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, GM-CSF and IFN-γ by A2780 cells in hypoxic conditions.
